Addressing challenges in developing a core domain set in adherence interventions in rheumatology

A report from the OMERACT-Adherence Group

Ayano Kelly, Susan J. Bartlett, Maarten P. De Wit, Dorcas E. Beaton, Therese Dawson, Vicki Evans, Michael Gill, Geraldine Hassett, Lyn March, Marieke Scholte-Voshaar, Jasvinder A. Singh, Allison Tong, Peter Tugwell, Peter Wong, Kathleen Tymms

Research output: Contribution to journalArticle


Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods: Forty participants from nine countries participated. Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

Original languageEnglish
Pages (from-to)1202-1206
Number of pages5
JournalJournal of Rheumatology
Issue number9
Publication statusPublished - Sep 2019


Cite this